Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO

Executive Summary

VP-Government Affairs Chuck Ludlum will leave the Biotechnology Industry Organization following the close of the 106th Congressional session, the association said Oct. 6. BIO said it will begin recruiting a successor soon. The group recently expanded its in-house lobbying team with the appointment of Stephan Lawton as VP-regulatory affairs and general counsel (1"The Pink Sheet" July 31, p. 11)

You may also be interested in...



BIO VP-Government Relations Rawls Has Been Frist Chief Of Staff For 4 Years

The Biotechnology Industry Organization's selection of Lee Rawls as VP-government relations strengthens the trade association's ties with the Senate Republican leadership.

BIO VP-Government Relations Rawls Has Been Frist Chief Of Staff For 4 Years

The Biotechnology Industry Organization's selection of Lee Rawls as VP-government relations strengthens the trade association's ties with the Senate Republican leadership.

BIO Brings Lawton In-House As VP-Reg Affairs/Counsel: PDUFA III Looms

Biotechnology Industry Organization VP-Regulatory Affairs Stephan Lawton will focus on the reauthorization of the Prescription Drug User Fee Act upon joining the association on Jan. 1, 2001.

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel